期刊文献+

瘢痕疙瘩的临床和流行病学特征 被引量:4

Clinical and epidemiological characterization of keloids in Chinese patients
下载PDF
导出
摘要 目的了解中国人瘢痕疙瘩患者的临床和流行病学的特点。方法采用SPSS13·0软件对550例瘢痕疙瘩先证者流行病学分析并用Falconer法计算遗传度。结果发病年龄(22·61±12·34)岁,男女之间差异无显著性。有家系患者比无家系患者病情更重且此种差异有显著性(χ2=8·430,P<0·05)。有家系患者中58·20%为多发患者,而无家系患者中该比例为47·40%,两者差异有显著性(χ2=5·167,P<0·05)。患者一、二和三级亲属的遗传度分别是71·55%、40·51%和17·14%,加权平均遗传度为58·89%。结论年轻人好发且无性别差异,遗传因素可能在发病中起重要作用。 Objective To explore the epidemiologie and clinic aspects of keloids in Chinese patients. Methods A total of 550 patients were enrolled and statistical analysis and heritability were performed using EPI INFO 6.0, SPSS10. 0, and the Falconer method. Results The mean ± SD age of onset was (22. 61 ± 12. 34 )years. A greater severity of keloids was seen in the positive history family group than the negative history family group and this difference was statistically significant (P 〈 0. 05 ). 58.2% of patients in the positive group presented with multiple site, compared with 47.4% of patients in the negative history family group. This difference was statistically significant (P 〈0. 05 ). The heritability of keloids in first, second and third degree relatives was 71.55%, 40. 51% and 17. 14%, respectively. Conclusion To our experience, keloids in Chinese patients are characterized by a younger age of onset, weaker female predominance. Our findings reveal that the most severe forms of keloids are seen in the probands with positive family history and the heritability in first-dgree relatives of probands is 71.55%. Those indicate genetic factors play important role in the hereditary composition of keloids .
出处 《安徽医科大学学报》 CAS 北大核心 2006年第3期346-348,共3页 Acta Universitatis Medicinalis Anhui
基金 国家863基金资助项目(编号:2001AA227031)
关键词 瘢痕疙瘩 流行病学 遗传度 keloids epidemiology heritability
  • 相关文献

参考文献14

  • 1Olabanji J K, Onayemi O, Olasode O A, et al. Keloids: An old problem still searching for a solution[ J]. Annals of the College of Surgeons Hong Kong, 2005, 9( 1 ) : 2 -7.
  • 2Mameros A G, Norris J E, Olsen B R, et al. Clinical genetics of familial keloids [ J ]. Arch Dermatol, 2001, 137 ( 11 ) : 1429 - 34.
  • 3Bayat A, Arscott G, Oilier W E, et al. Keloid disease: clinical relevance of single versus multiple site scars[ J], Br J Plast Surg,2005, 58 ( 1 ) : 28 - 37.
  • 4Ramakrishnan K M, Thomas K P, Sundararajan C R. Study of 1,000 patients with keloids in South India[J]. Plast Reconstr Surg,1974, 53(3) : 276 -80.
  • 5Marneros A G, Krieg T. Keloids-clinical diagnosis, pathogenesis,and treatment options[J]. J Dtsch Dermatol Ges, 2004, 2( 11 ) :905 - 13.
  • 6Emery A E H. Methodology in Medical Genetics[J]. New York:Churchill Livingston, 1986 : 59.
  • 7English R S, Shenefelt P D. Keloids and hypertrophic scars[J].Dermatol Surg, 1999, 25(25) : 631 -8.
  • 8Urioste S S, Arndt K A, Dover J S. Keloids and hypertrophic scars: review and treatment strategies [ J ]. Semin Cutan Med Surg, 1999,18(2): 159-71,
  • 9Davies D M. Plastic and reconstructive surgery, Scars, hypertrophic sears, and keloids[J]. Br Med J (Clin Res Ed), 1985,290(6474) : 1056 -8,
  • 10Cosman B, Crikelair G F, Ju D M C, et al. The surgical treatment of keloids[ J]. Plast Reconstr Surg, 1961,27:335-56.

同被引文献63

  • 1陈良良,黄健飞.丹参及其提取物对肿瘤转移影响的研究述评[J].浙江中医药大学学报,2006,30(4):449-452. 被引量:11
  • 2Massague J,Wotton D.Transcriptional control by the TGF-beta/Smad signaling system[J].Embo J,2000,19(8):1745-54.
  • 3Xu L.Regulation of Smad activities[J].Biochim Biophys Acta,2006,1759(11-12):503-13.
  • 4Tsujita-Kyutoku M,Uehara N,Matsuoka Y et al.Comparison of transforming growth factor-beta/Smad signaling between normal dermal fibroblasts and fibroblasts derived from central and peripheral areas of keloid lesions[J].In Vivo,2005,19(6):959-63.
  • 5Yang Y,Yang S,Chen M,et al.Compound Astragalus and Salvia miltiorrhiza extract exerts anti-fibrosis by mediating TGF-beta/Smad signaling in myofibroblasts[J].J Ethnopharmacol,2008,118(2):264-70.
  • 6Liu X,Yang Y,Zhang X X,et al.Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating trorming ansfgrowth factor-β/Smad in HepG2 cell[J].J Gastroenterol Hepatol,2009,25(1):420-6.
  • 7Olabanji J K,Onayemi O,Olasode O A,et al.Keloids:An old problem still searching for a solution[J].Surg Pract,2005,9(1):2-7.
  • 8Schiller M,Javelaud D,Mauviel A.TGF-β-induced SMAD signaling and gene regulation:consequences for extracellular matrix remodeling and wound healing[J].J Derma Sci,2004,35(2):83-92.
  • 9Phan T T,Lim I J,Chan S Y,et al.Suppression of transforming growth factor beta/smad signaling in keloid-derived fibroblasts by quercetin:implications for the treatment of excessive scars[J].J Trauma,2004,57(5):1032-7.
  • 10He S,Liu X,Yang Y,et al.Mechanisms of transforming growth factor (1/Smad signaling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts[J].Br J Dermatol,2009,162(3):538-46.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部